Female gender as a risk factor for drug-induced cardiac arrhythmias: Evaluation of clinical and experimental evidence

Journal of Women's Health

Volumn 7, Issue 5, 1998, Pages 547-557

  Ebert, Steven N ^a   Liu, Xiao K E ^a   Woosley, Raymond L ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; ASTEMIZOLE; ERYTHROMYCIN; HALOFANTRINE; QUINIDINE; SOTALOL; TERFENADINE;

ANIMAL TISSUE; FEMALE; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; ION CURRENT; ISOLATED HEART; MALE; MUSCLE CELL; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; RABBIT; REVIEW; RISK FACTOR; SEX DIFFERENCE; TORSADE DES POINTES;

EID: 0031875672     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1998.7.547     Document Type: Review

References (50)

1. Dessertenne F. [Ventricular tachycardia with 2 variable opposing foci]. Arch Mal Coeur Vaiss 1966; 59:263.
2. Asano Y, Davidenko JM, Baxter WT, Gray RA, Jalife J. Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart [see Comments]. J Am Coll Cardiol 1997; 29:831.
3. El-Sherif N, Caref EB, Yin H, Restivo M. The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome. Tridimensional mapping of activation and recovery patterns. Circ Res 1996;79: 474.
4. Leenhardt A, Glaser E, Burguera M, Nurnberg M, Maison-Blanche P, Coumel P. Short-coupled variant of torsade de pointes. Circulation 1994;89:206.
5. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80:795.
6. Kr potassium channel. Cell 1995;81:299.
7. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nature Genet 1996;12:17.
8. Duggal P, Vesely MR, Wattanasirichaigoon D, Villafane J, Kaushik V, Beggs AH. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long-QT syndrome. Circulation 1998;97:142.
9. Roden DM, Lazzara R, Rosen M, Schwarte PJ, Towbin J, Vincent M. Multiple mechanisms in the long QT syndrome. Current knowledge, gaps, and future directions. Circulation 1996;94:1996.
10. Lazzara R. Mechanisms and management of congenital and acquired long QT syndromes. Arch Mal Coeur Vaiss 1996;89(Spec No. 1):51.
11. KS cardiac potassium current. Nature 1996;384:78.
12. Benson DW, MacRae CA, Vesely MR, et al. Missense mutation in the pore region of HERG causes familial long QT syndrome. Circulation 1996;93:1791.
13. Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805.
14. Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 1991;84:1136.
15. Zareba W, Moss AJ, Le Cessie S, et al. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol 1995;26:1685.
16. Liu XK, Katchman A, Drici MD, et al. Gender difference in the cycle length-dependent QT and potassium currents. J Pharmacol Exp Ther 1998;285:672.
17. Abinader A, Shahar B. Possible female preponderance in prenylamine-induced "torsades de pointes" tachycardia. Cardiology 1983;70:37.
18. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993;270:2590.
19. Reinoehl J, Frankovich D, Machado C, et al. Probucol-associated tachyarrhythmic events and QT prolongation: Importance of gender. Am Heart J 1996;131:1184.
20. Kawasaki R, Machado C, Reinoehl J, et al. Increased propensity of women to develop torsades de pointes during complete heart block. J Cardiovasc Electrophysiol 1995;6:1.
21. Waldo AL, Camm AJ, deRuyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival with oral d-sotalol [see Comments] [published erratum appears in Lancet 1996;348(9024):416]. Lancet 1996; 348:7.
22. Bazett HC. An analysis of the time relationship of electrocardiograms. Heart 1920;7:353.
23. Rautaharju PM, Zhou SH, Wong S, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1991;8:690.
24. Lehmann MH, Timothy KW, Frankovich D, et al. Age-gender infleunce on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol 1997;29:93.
25. Woosley RL. CAST: Implications for drug development. Clin Pharmacol Ther 1990;47:553.
26. MacNeil DJ. The side effect profile of class III antiarrhythmic drugs. Focus on d,l-sotalol. Am J Cardiol 1997;80:90G.
27. Roden D, Woosley R, Primm R. Incidence and clinical features of the quinidine-associated long-QT syndrome: Implications for patient care. Am Heart J 1986;111:1088.
28. Thompson KA, Murray JJ, Blair IA, Woosley RL, Roden DM. Plasma concentrations of quinidine, major metabolites, and dihydroquinidine in patients with torsades de pointes. Clin Pharmacol Ther 1988;43:636.
29. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269:1532.
30. Woosely RL. Do H1 blockers astemizole (Hismanal) and terfenadine (Seldane) cause torsades de pointes? Eur J Cardiac Pac Elect 1994;4:15.
31. Woosley RL. Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol 1996;36:233.
32. Selzer A, Wray HW. Quinidine syncope: Paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias. Circulation 1964;30:17.
33. Locati EH, Maison-Blanche P, Dejode P, Cauchemez B, Coumel P. Spontaneous sequences of onset of torsades de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings. J Am Coll Cardiol 1995;25:1564.
34. Carlsson L, Almgren O, Duker G. QTU-prolongation and torsade de pointes induced by putative class III antiarrhythmic agents in the rabbit: Etiology and interventions. J Cardiovasc Pharmacol 1990;16:276.
35. Roden DM. Early after-depolarizations and torsade de pointes: Implications for the control of cardiac arrhythmias by prolonging repolarization. Eur Heart J 1993;14(Suppl. H):56.
36. El-Sherif N, Bekheit SS, Henkin R. Quinidine-induced long QTU interval and torsade de pointes: Role of bradycardia-dependent early afterdepolarizations. J Am Coll Cardiol 1989;14:252.
37. ++ current. Circ Res 1989;64:977.
38. +-induced early afterdepolarizations in Purkinje fibers. J Cardiovasc Electrophysiol 1995;5:933.
39. Funck-Brentano C, Lineberry MD, Light RT, Wright GM, Roden DM, Woosley RL. Pharmacokinetic and pharmcodynamic interaction on N-acetyl procainamide and procainamide in man. J Cardiovasc Pharmacol 1989;14:364.
40. Woosley RL, Barbey JT, Wang T, Funck-Brentano C. Concentration/response relations for the multiple antiarrhythmic actions of sotalol. Am J Cardiol 1990; 95:22A.
41. Pinney SP, Koller BS, Franz MR, Woosley RL. Terfenadine increases the QT interval in isolated guinea pig heart. J Cardiovasc Pharmacol 1995;25:30.
42. Funck-Brentano C, Silberstein DJ, Roden DM, Wood AJJ, Woosley RL. Mechanism of D-sotalol effects on heart rate not related to beta adrenoceptor antagonism. Br J Clin Pharmacol 1990;30:195.
43. Drici MD, Knollmann B, Wang W-X, Woosley RL. Gender and reports of erythromycin-related arrhythmias. Circulation 1997;96:I-211.
44. Drici MD, Dale M, Burnett A, Woosley RL. RR-QT relationships differ during exercise- and isoproterenol-induced tachycardia. Clin Pharmacol Ther 1996;59: 189.
45. Roden DM, Bennett PB, Snyders DJ, Balser JR, Hondeghem LM. Quinidine delays IK activation in guinea pig ventricular myocytes. Circ Res 1988;62:1055.
46. Noble D, Noble SJ, Bett GC, Earm YE, Ho WK, So IK. The role of sodium-calcium exchange during the cardiac action potential. Ann NY Acad Sci 1991;639: 334.
47. OXSOFT, Ltd. HEART, version 3.6 [computer software]. Oxford: Medical Research Universitet USLO.
48. Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations: Role of M cells in the generation of U waves, triggered activity and torsades de pointes. J Am Coll Cardiol 1994;23:259.
49. Surawicz E. Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations? J Am Coll Cardiol 1989;14:172.
50. Drici MD, Burklow TR, Haridasse V, Glazer RI, Woosley RI. Sex hormones prolong the QT interval and down-regulate potassium channel expression in the rabbit heart. Circulation 1996;94:1471.